iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $450.62)
- $450.62 P/E (TTM): 57.81X Cap: $160.02B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $436.27)
- $436.27 P/E (TTM): 29.22X Cap: $111.01B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $207.94)
- $207.94 P/E (TTM): 90.0X Cap: $367.79B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $238.46)
- $238.46 P/E (TTM): 21.88X Cap: $574.35B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $939.47)
- $939.47 P/E (TTM): 41.62X Cap: $887.62B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.42)
- $121.42 P/E (TTM): 16.85X Cap: $300.06B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $563.00)
- $563.00 P/E (TTM): 44.71X Cap: $44.76B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $67.82)
- $67.82 P/E (TTM): 26.51X Cap: $8.03B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $96.07)
- $96.07 P/E (TTM): 15.13X Cap: $19.11B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.94)
- $24.94 P/E (TTM): 15.15X Cap: $3.04B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.28)
- $28.28 P/E (TTM): 373.92X Cap: $235.79B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $129.44)
- $129.44 P/E (TTM): 17.2X Cap: $7.82B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $193.03)
- $193.03 Cap: $27.35B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $26.68)
- $26.68 P/E (TTM): 27.48X Cap: $1.26B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $24.94)
- $24.94 P/E (TTM): 15.15X Cap: $3.04B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $172.97)
- $172.97 P/E (TTM): 20.1X Cap: $25.38B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $138.99)
- $138.99 P/E (TTM): 20.99X Cap: $172.54B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $120.93)
- $120.93 P/E (TTM): 22.61X Cap: $18.37B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $207.94)
- $207.94 P/E (TTM): 90.0X Cap: $367.79B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $100.30)
- $100.30 P/E (TTM): 27.61X Cap: $174.68B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $939.47)
- $939.47 P/E (TTM): 41.62X Cap: $887.62B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $37.52)
- $37.52 P/E (TTM): 10.52X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $129.44)
- $129.44 P/E (TTM): 17.2X Cap: $7.82B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $34.51)
- $34.51 P/E (TTM): 27.89X Cap: $3M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025